Vaccine-preventable diseases and immunization


WHO welcomes global health funding for malaria vaccine

The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa as funding has now been secured for the initial phase of the programme and vaccinations are due to begin in 2018.

The vaccine, known as RTS,S, acts against P. falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.

RTS,S was developed through a partnership between GlaxoSmithKline and the PATH Malaria Vaccine Initiative (MVI), with support from the Bill & Melinda Gates Foundation and from a network of African research centres.

Read more about global health funding for malaria vaccine


Progress towards measles elimination in the Region

19 November 2017 – The Eastern Mediterranean Region has witnessed remarkable progress in measles control in the last 2 decades with several countries close to achieving elimination. A journal article entitled...

» Read the full story

23 June 2016 -- The Gavi Vaccine Alliance has announced that it will support a WHO-coordinated pilot programme for the malaria vaccine RTS,S/AS01 (RTS,S). In a statement issued today, GAVI...

» Read the full story

In focus

In May 2012, the Sixty-fifth World Health Assembly endorsed the Global Vaccine Action Plan in resolution WHA65.17 as the operational framework for implementation of the vision of the Decade of...

» Read the full story


World Immunization Week – celebrated in the last week of April – aims to promote the use of vaccines to protect people of all ages against disease. Immunization saves millions...

» Read the full story